IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$76M+234.1% YoY

Gross Profit

$51M66.5% margin

Operating Income

-$169M-221.6% margin

Net Income

-$190M-248.1% margin

EPS (Diluted)

$-1.39

Cash Flow

Operating Cash Flow

-$156M

Free Cash Flow

-$159M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$334M

Total Liabilities

$245M

Stockholders' Equity

$89M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$23M	+234.1%
Gross Profit	$51M	$16M	+224.4%
Operating Income	-$169M	-$252M	+32.8%
Net Income	-$190M	-$273M	+30.5%

IRWD FY 2014 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena